WikiNow lets you discover the news you care about, follow the topics that matter to you and share your favourite stories with your friends.

© WikiNow

The inhibitor protein is situated in the mitochondrial matrix and protects the cell against rapid ATP hydrolysis during momentary ischaemia. In oxygen absence, the pH of the matrix drops. This causes IP to become protonated and change its conformation to one that can bind to the F1Fo synthetase and stops it thereby preventing it from moving in a backwards direction and hydrolyze ATP instead of make it. When oxygen is finally incorporated into the system, the pH rises and IP is deprotonated. IP dissociates from the F1Fo synthetase and allows it to resume its ATP synthesis.

The inhibitor protein (IP) is situated in the mitochondrial matrix and protects the cell against rapid ATP hydrolysis during momentary ischaemia. In oxygen absence, the pH of the matrix drops. This causes IP to become protonated and change its conformation to one that can bind to the F1Fo synthetase and stops it thereby preventing it from moving in a backwards direction and hydrolyze ATP instead of make it. When oxygen is finally incorporated into the system, the pH rises and IP is deprotonated. IP dissociates from the F1Fo synthetase and allows it to resume its ATP synthesis.

Pharmacology – ANTIBIOTICS – DNA, RNA, FOLIC ACID, PROTEIN SYNTHESIS INHIBITORS (MADE EASY)

Support us on Patreon: https://www.patreon.com/speedpharmacology Follow us on Facebook: https://www.facebook.com/SpeedPharmacology/ Get Speed ...

PROTEIN SYNTHESIS INHIBITOR : ANTIBIOTICS | PHARMACOLOGY | GPAT-2020

Visit our website :- http://www.gdc4gpat.com Download GDC App:- https://goo.gl/uaGsY2 Join GDC Online Test:- http://www.gdconlinetest.in/ FACEBOOK- ...

50s ribosome inhibitor mode of action

This antibiotic video tutorial explains the mode of action of 50s ribosome inhibitor antibiotics. These antibiotics are among protein biosynthesis inhibitors.

Targeting Inhibitor of Apoptosis Proteins for Cancer Therapy: A Double-Edge Sword?

Understanding the Pathway article: http://ascopubs.org/doi/full/10.1200/JCO.2014.56.8741 The Journal of Clinical Oncology's "Understanding the Pathway" ...

DRUG-LIKE INHIBITORS OF PROTEIN-PROTEIN INTERACTIONS: PEPTIDE MIMICRY AND FRAGMENT APPROACHES

David Fry at Boulder Peptide Symposium 2012, Head Biostructures Group, Roche Research Center, Nutley, NJ.

PARP-inhibitors: A New Generation of Cancer Drugs

First of new generation of cancer drugs granted European approval A new drug for ovarian cancer, developed by researchers at the University of Cambridge ...